AbCellera Biologics Inc. (ABCL) Insider Trading

Name: AbCellera Biologics Inc. (ABCL) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 24, 2026): Michael R. Hayden (Director): Purchase of 53,613 shares, $570.4K.

Get alerted when insiders trade ABCL

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta